AKT1 and cancer: These results are corroborated by Kenyon et al. who highlighted that CBD administration in combination with other cancer treatment therapies promotes disruption of intracellular signaling pathways like P13K/AKT/mTOR and ERK, which improves the combinative treatment cell death outcomes [53].